INJECTABLES/ IV/INFUSION
MERIKEY™ SB 1.5
Meropenem 1gm + Sulbactam 500mg
Dosage Form
Injection
Packing
VIAL
MRP
₹1699
Prescribed By
Critical Care, Infectious Disease, Pulmonology, ICU Medicine
Quick Facts
Form
Injection
Pack
1 Vial
MRP
Rs.1699
Prescribed By
Critical Care, Infectious Disease, Pulmonology, ICU Medicine
Key Benefits
01
Carbapenem plus Sulbactam — covers even the most resistant hospital pathogens.
02
Active against carbapenem-resistant Acinetobacter baumannii.
03
Essential for XDR infections where other antibiotics have failed.
04
Critical ICU antibiotic for the most challenging resistant infections.
Mechanism of Action
Meropenem provides carbapenem-level broad-spectrum antibacterial activity. Sulbactam adds specific activity against Acinetobacter baumannii — one of the most dangerous and resistant hospital pathogens. This combination covers even carbapenem-resistant Acinetobacter.
Indications
Carbapenem-resistant Acinetobacter infections, XDR (extensively drug resistant) infections, severe ICU infections.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why MERIKEY™ SB 1.5?
MERIKEY™ SB 1.5 is a last-resort combination for the most resistant hospital infections — adding Sulbactam's Acinetobacter activity to Meropenem for XDR and carbapenem-resistant cases.
